Search

everythinglearnresearchcommunity

for

Search:↓

A surface with VEGF can specifically capture endothelial cells from flowing fluids.

Promising cancer treatments were found, but the manufacturer closed.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

Symptom experience doesn't affect medication compliance in liver transplant patients.

Exosomes show promise as effective treatments for autoimmune skin diseases with fewer side effects.

Higher IL-17A levels indicate more severe alopecia areata.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Erythema multiforme-like lesions can occur in lupus without drug use or herpes infection.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Candida antigen is an effective and promising treatment for alopecia areata.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Systemic lupus erythematosus is an autoimmune disease causing diverse symptoms and major organ involvement.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.